GILD / Gilead Sciences Inc
as of 2026-02-11
Bias: MixedRisk: ElevatedMixed structure, RSI overbought, risk elevated
Last
155.8
1D +5.82% • 5D +6.54% • 1M +27.08%
Updating…
Job #6019 • queued • 0/0 requests
Company
Gilead Sciences Inc, founded in 1987, is a leading biopharmaceutical company headquartered in Foster City, California. The company specializes in the research and development of antiviral drugs, particularly for the treatment of HIV, Hepatitis B, Hepatitis C, and influenza. Gilead's portfolio includes several groundbreaking therapies that have transformed the treatment landscape for these diseases. The company is committed to advancing its pipeline of therapies to address unmet medical needs and improve patient outcomes worldwide.
Mini chart (last 120 D1 closes)
2025-09-19 → 2026-02-11
1D
+5.82%
5D
+6.54%
1M
+27.08%
Vol (20d)
33.7%
Weather meter
Δ +0
Overall57
Trend60
Volatility58
Sentiment50
Technicals
MA20
138.98
Above short-term trend
MA50
128.84
Above medium-term trend
MA200
—
RSI14
82.4
Overbought
What traders watch now
Support (MA50)
128.84
Resistance (MA200)
—
Key risk
Momentum exhaustion
Time horizon
2–10 trading days